Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Open letter on the conflicts of interest with the seed industry of a national expert seconded to DG SANCO

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

To: Commissioner T. Borg

Cc: Commissioners D. Ciolos, J. Potočnik, Secretary General of the Commission C. Day

Dear Commissioner,

We are writing to you in order to express our concerns about the conflict of interests of Madame Isabelle Clément-Nissou, a national expert seconded from France to DG SANCO. She is now a ‘Policy Officer on Seed and Reproductive Material’ working to support the drafting of future legislation on these dossiers, notably the key upcoming review of the EU legislation on the Marketing of Seed and Plant Propagating Material (S&PM). In our view, Madame Clément-Nissou appears to be in a situation explicitly forbidden by rules on the secondment of national experts to the Commission which state: in order to ensure that the Commission's independence is not compromised by private interests, it should be stipulated that seconded national experts must come from a national, regional or local public administration or an IGO(public intergovernmental organization)." 1

Although Mrs. Clément-Nissou is supposed to be sent by the French Government, she was actually sent on behalf of GNIS (Groupement National Interprofessionnel des Semences), where she was Director of International Relations until September 2011 when she joined DG SANCO. The reason the French Agriculture Ministry sent her may have been because of the French administration's highly unusual relationship with GNIS: although this organisation is a private and commercial organisation representing the seed sector, it has been entrusted (since 1941) with the public service of controlling and monitoring seed quality as well as levying a tax on sales of seeds throughout France. Despite its public role, GNIS is a privately funded lobby group run by and staunchly defending the interests of the seed industry: the fact that this organisation has been entrusted to a public service does not make it a “national, regional or local public administration or an IGO. The fact that France has largely given away the direction of its seed policy to industry is problematic, but this situation should not be allowed to negatively influence the drafting of EU legislation.

We therefore ask you that the contract as seconded national expert of the person at stake is terminated and that appropriate action is taken to make sure that DG SANCO's work is not affected by conflicts of interests in the future.

With kind regards,

Ivan Mammana, Martin Pigeon
Researchers and campaigners at Corporate Europe Observatory

 

Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
This must-watch film is now online. The film shows how corporations and actors within the Commission are teaming up to demolish a major piece of public health legislation.
Campaign groups today called on members of the European Parliament to back citizens' demands for improved rules to prohibit the cultivation of genetically modified (GM) crops. A letter signed by five environment, consumers and farmers groups was sent to all members of the parliament's environment committee, which will debate this controversial issue later in the week.
A few observations on the debate sparked by our open letter on the position of Chief Scientific Advisor to the President of the European Commission, and on the need for proper scientific advice to EU legislators.
A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.

Corporate Europe Forum